Veru Inc. [NASDAQ: VERU] gained 0.53% on the last trading session, reaching $3.78 price per share at the time. The company report on March 2, 2023 that Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
In communicating its decision, the FDA stated that despite the FDA declining to issue an EUA for sabizabulin at this time, the FDA remains committed to working with the Company for the development of sabizabulin.
Veru Inc. represents 80.56 million in outstanding shares, while the company has a total market value of $325.50 million with the latest information. VERU stock price has been found in the range of $3.645 to $3.83.
If compared to the average trading volume of 2.28M shares, VERU reached a trading volume of 2685959 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Veru Inc. [VERU]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VERU shares is $11.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VERU stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Veru Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 13, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $12 to $17. The new note on the price target was released on February 09, 2021, representing the official price target for Veru Inc. stock. Previously, the target price had yet another raise from $4.50 to $6, while H.C. Wainwright kept a Buy rating on VERU stock.
The Average True Range (ATR) for Veru Inc. is set at 0.35, with the Price to Sales ratio for VERU stock in the period of the last 12 months amounting to 11.75. The Price to Book ratio for the last quarter was 6.20, with the Price to Cash per share for the same quarter was set at 0.54.
Trading performance analysis for VERU stock
Veru Inc. [VERU] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -14.48. With this latest performance, VERU shares dropped by -34.38% in over the last four-week period, additionally sinking by -77.08% over the last 6 months – not to mention a drop of -32.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VERU stock in for the last two-week period is set at 29.25, with the RSI for the last a single of trading hit 24.79, and the three-weeks RSI is set at 32.80 for Veru Inc. [VERU]. The present Moving Average for the last 50 days of trading for this stock 5.19, while it was recorded at 3.93 for the last single week of trading, and 10.42 for the last 200 days.
Veru Inc. [VERU]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Veru Inc. [VERU] shares currently have an operating margin of -211.47 and a Gross Margin at +77.55. Veru Inc.’s Net Margin is presently recorded at -212.88.
Return on Equity for this stock declined to -71.87, with Return on Assets sitting at -53.31.
Veru Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.80.
An analysis of insider ownership at Veru Inc. [VERU]
There are presently around $176 million, or 49.10% of VERU stock, in the hands of institutional investors. The top three institutional holders of VERU stocks are: CANDRIAM S.C.A. with ownership of 10,216,487, which is approximately 170.195% of the company’s market cap and around 19.22% of the total institutional ownership; PERCEPTIVE ADVISORS LLC, holding 7,858,011 shares of the stock with an approximate value of $29.7 million in VERU stocks shares; and MORGAN STANLEY, currently with $27.57 million in VERU stock with ownership of nearly 14.966% of the company’s market capitalization.
69 institutional holders increased their position in Veru Inc. [NASDAQ:VERU] by around 14,532,622 shares. Additionally, 67 investors decreased positions by around 7,368,980 shares, while 29 investors held positions by with 24,704,997 shares. The mentioned changes placed institutional holdings at 46,606,599 shares, according to the latest SEC report filing. VERU stock had 23 new institutional investments in for a total of 668,333 shares, while 33 institutional investors sold positions of 2,677,372 shares during the same period.